The Effect of Liraglutide on Insulin-associated wEight GAiN in Patients With Type 2 Diabetes Mellitus (ELEGANT Trial)
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2016
At a glance
- Drugs Liraglutide (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Acronyms ELEGANT
- 01 Aug 2013 Planned End Date changed from 1 Sep 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 01 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Mar 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.